Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
MedPage Today on MSN
Two Types of ADT for Prostate Cancer, Different Effects on Coronary Artery Plaque
Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...
The REVELUTION (Relugolix versus Leuprolide Cardiac) trial compared coronary plaque after 2 types of androgen deprivation therapy (ADT) for prostate cancer.
PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of international research on androgen deprivation therapy (ADT) for prostate cancer ...
New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients ...
"There is no evidence that ADT followed by brachytherapy increases the chance of cure in comparison to other treatments, such an external beam radiation therapy alone, in these men with favorable risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results